TRVI logo
TRVI NASDAQ US

Trevi Therapeutics, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO May 2019
$11.94
▲ +$0.36 (+3.11%)
Vol 1.2M
3
Quality Score
fail
Mkt Cap
$1.6B
ROE
-31.2%
D/E
0.00
Beta
0.89
52W
$3–$14

Wall Street Consensus

18 analysts · Apr 2026
6
Strong Buy
11
Buy
1
Hold
0
Sell
0
Strong Sell
94.4%
Buy Rating

Price Chart

Similar Stocks

AMLX
Amylyx Pharmaceuticals Inc
$1.3B
RAPP
Rapport Therapeutics Inc
$1.4B
HRMY
Harmony Biosciences Holdings Inc
P/E 11.6
$2.2B
MBX
MBX Biosciences Inc
$1.4B
MAZE
Maze Therapeutics Inc
$2.0B
ATAI
AtaiBeckley Inc
$1.5B
HROW
Harrow Inc
$1.8B
SEPN
Septerna Inc
$1.2B
EYPT
EyePoint Inc
$1.5B

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.10 $-0.06 +$0.04
Sep 2025 $-0.10 $-0.08 +$0.02
Jun 2025 $-0.10 $-0.09 +$0.01
Mar 2025 $-0.12 $-0.09 +$0.03

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -41.2% -41.4% -40.4% -40.4% -41.2% -31.2%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 22.42 22.42 22.40 22.40 22.42 21.93

Key Ratios

ROA (TTM)
-29.3%
P/B
3.6
EPS (TTM)
$-0.37
CF/Share
$-0.57
52W High
$14.39
52W Low
$3.47
$3.47 52-Week Range $14.39

How does TRVI compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

TRVI AARD ACB ACRS ADIL

TRVI valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
3.6
▲ 72% above peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

TRVI profitability vs Pharmaceuticals peers

ROE
-31.2%
▲ 42% above peers (-54.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼ 0% below peers (-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-29.3%
▲ 22% above peers (-37.4%)
vs Peers
vs Industry
Below avg

TRVI financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
21.9
▲ 553% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.9
▼ 5% below peers (0.9)
vs Peers
vs Industry
Less volatile

TRVI fundamentals radar

TRVI Peer median Industry

TRVI profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

TRVI vs peers: key metrics

Latest News

No related news yet